On September 14, 2020, our Phoenix laboratory began performing a portion of our alternate donor antibody screen on the Ortho Clinical Diagnostics VISION Analyzer. This instrumentation change was necessary as Ortho Clinical Diagnostics will be discontinuing support of the existing ProVue instrumentation in the future.
We will notify you of the transition date of our other four laboratories. To read more about this change, click here: Communications
Reminder: On Wednesday August 15, 2018 at 11:00AM PDT, we will be hosting a webinar regarding the ch...
CTS implement the Bio-Rad Geenius HIV 1/2 supplemental assay on Monday September 21, 2020. The newly...
Creative Testing Solutions, the largest nonprofit blood testing organization in the U.S., today anno...
On December 9, 2019, the new CTS Laboratory Information System successfully implemented in Phoe...
On January 25, 2021, CTS implements the Ortho VIP viral marker testing platform. Conversion from the...
As communicated on January 21, 2020, CTS will implement the licensed Grifols Babesia test for sample...